Tokiwa-Bio respond to unmet medical needs for there is lacking of effective treatment. Developing a safe gene therapeutics by utilizing Stealth RNA Vector (SRV), which is a unique gene expression system, the purpose is to help curing people that are suffering genetic diseases worldwide.
To achieve this purpose, Tokiwa-Bio will do the best through the following corporate philosophy.
・Tokiwa Bio will constantly developing creative technologies for gene-cell-therapy.
・Tokiwa Bio will continually developing innovative technologies for pharmaceutics to meet diverse medical needs.
・Tokiwa Bio will contribute to society through innovative approaches in regenerative drug discovery.

Expanding Stealth RNA Vector (SRV) the Japan-origin technology, for the advanced medical field, TOKIWA-Bio will dedicate to the breakthrough of gene-therapy medicine as well in the field of regenerative medicine and keep up with the competitiveness in Japan.

A Japanese venture company, developing businesses with the goal of contributing to the world in the field of gene/cell therapy and regenerative medicine.

As a fair, sincere and trustworthy member of the society, pursue businesses with ambition and honesty contributing values that are useful to the society.